|
ZFAND3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.092100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.620900E-04 |
| Normal-vs-Stage2 |
9.682000E-01 |
| Normal-vs-Stage3 |
4.913400E-01 |
| Normal-vs-Stage4 |
1.913760E-01 |
| Stage1-vs-Stage2 |
1.874590E-01 |
| Stage1-vs-Stage3 |
8.132400E-02 |
| Stage1-vs-Stage4 |
9.941800E-01 |
| Stage2-vs-Stage3 |
6.244200E-01 |
| Stage2-vs-Stage4 |
3.677600E-01 |
| Stage3-vs-Stage4 |
1.554430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.224200E-02 |
| Normal-vs-AfricanAmerican |
2.328400E-01 |
| Normal-vs-Asian |
6.247900E-04 |
| Caucasian-vs-AfricanAmerican |
7.528600E-01 |
| Caucasian-vs-Asian |
2.878000E-01 |
| AfricanAmerican-vs-Asian |
1.609980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.144000E-03 |
| Normal-vs-Female |
7.654800E-01 |
| Male-vs-Female |
1.381770E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.815800E-02 |
| Normal-vs-Extreme_Weight |
1.081850E-02 |
| Normal-vs-Obese |
7.838200E-01 |
| Normal-vs-Extreme_Obese |
1.719410E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.984600E-01 |
| Normal_Weight-vs-Obese |
5.945600E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.425800E-01 |
| Extreme_Weight-vs-Obese |
3.308000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.443200E-01 |
| Obese-vs-Extreme_Obese |
2.881000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.579600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.264300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.171800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.016300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.593790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.773900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.832100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.738400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.257800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.458200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.421900E-03 |
| Normal-VS-Type2 PRCC |
7.350600E-01 |
| Normal-VS-KIRP CIMP |
3.389600E-01 |
| Normal-VS-Unclassified PRCC |
7.208000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.212600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.581210E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.683000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.151800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.463200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.775350E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.559800E-01 |
| Normal-vs-N1 |
4.834400E-01 |
| Normal-vs-N2 |
3.702000E-02 |
| N0-vs-N1 |
1.493640E-01 |
| N0-vs-N2 |
8.232200E-01 |
| N1-vs-N2 |
3.138800E-01 |
|
|
